<DOC>
	<DOCNO>NCT02304445</DOCNO>
	<brief_summary>This randomize , open-label , active comparator-controlled trial subject advance ( Barcelona stage B/C ) hepatocellular carcinoma . Subjects receive one treatment Trans-Arterial Chemo-Embolization ( TACE ) prior randomization . Subsequently , subject randomize observation , indicate , additional TACE treatment , Stereotactic Body Radiotherapy ( SBRT ) . Tumor response follow intervention evaluate three month .</brief_summary>
	<brief_title>Chemoembolization With Without Stereotactic Body Radiosurgery Liver Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Chlorotrianisene</mesh_term>
	<criteria>Hepatocellular carcinoma ( Barcelona Stage B C ) Treatment Stereotactic Body Radiosurgery occur within 6 week enrollment Age ≥ 18 year ≤ 70 year Eastern Cooperative Oncology Group Performance status ≤ 2 Patient ) Radiographic enhance liver lesion early wash triple phase CT MRI b ) histological confirmation HCC determine Liver Tumor Board Hemoglobin &gt; 10.0 g/dL Total bilirubin &gt; 3.0 mg/dL AST ( SGOT ) ≤ 3x institutional upper limit normal ALT ( SGPT ) ≤ 3x institutional upper limit normal Absolute neutrophil count ≥ 1,500/μl Platelet count ≥ 50,000/μl ( may posttransfusion clinically indicate ) Aggregate maximal dimension liver tumor ≤ 8 cm Cirrhosis classify Child Pugh Class A B ( score ≤ 7 ) Determined treat physician medically eligible liver transplantation measure imaging modality ( MRI/CT scan ) three month post final treatment Life expectancy ≥ 12 week Ability understand study provide legally effective write informed consent Women childbearing potential must negative test within 4 week start SBRT treatment must pregnant nursing child Sexually active woman must agree use accepted form birth control throughout study , include abstinence , oral contraceptive ( birth control pill ) , IUD , diaphragm spermicide , Norplant , hormone injection , condom spermicide , documentation medical sterilization History abdominal radiation Cirrhosis classify Child Pugh Class B score ≥ 8 Prior invasive malignancy primary liver malignancy ( except nonmelanomatous skin cancer ) unless disease free minimum 3 year Evidence metastatic disease prior registration Evidence main portal vein thrombosis History cardiac ischemia stroke within 6 month prior enrollment Any concurrent medical psychosocial condition prohibits major surgical procedure immunosuppressant would constitute contraindication liver transplantation History sorafenib therapy within 21 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Radiotherapy</keyword>
	<keyword>Chemoembolization</keyword>
</DOC>